1/1
08:00 am
rxrx
Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. [Yahoo! Finance]
Low
Report
Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. [Yahoo! Finance]
1/1
07:15 am
rxrx
Cathie Wood's ARK Investment Buys 755K Shares Of Recursion Pharmaceuticals, Inc. (RXRX) [Yahoo! Finance]
Low
Report
Cathie Wood's ARK Investment Buys 755K Shares Of Recursion Pharmaceuticals, Inc. (RXRX) [Yahoo! Finance]
12/29
12:11 pm
rxrx
Recursion Pharmaceuticals Reports Positive Phase 1b/2 TUPELO Trial Results, Validating AI-Driven Therapy for FAP [Yahoo! Finance]
Neutral
Report
Recursion Pharmaceuticals Reports Positive Phase 1b/2 TUPELO Trial Results, Validating AI-Driven Therapy for FAP [Yahoo! Finance]
12/28
12:57 pm
rxrx
Recursion Pharmaceuticals Rises as Positive Phase 1b/2 Trial Results for REC-4881 Validate AI-Driven Drug Discovery Platform [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals Rises as Positive Phase 1b/2 Trial Results for REC-4881 Validate AI-Driven Drug Discovery Platform [Yahoo! Finance]
12/24
12:08 pm
rxrx
Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here? [Yahoo! Finance]
Low
Report
Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here? [Yahoo! Finance]
12/22
10:34 am
rxrx
How Investors May Respond To Recursion Pharmaceuticals (RXRX) Early FAP Trial Success And AI Platform Validation [Yahoo! Finance]
Low
Report
How Investors May Respond To Recursion Pharmaceuticals (RXRX) Early FAP Trial Success And AI Platform Validation [Yahoo! Finance]
12/21
05:16 pm
rxrx
Recursion Pharmaceuticals (RXRX): Valuation Check After Encouraging TUPELO Trial Data and Analyst Upgrades [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals (RXRX): Valuation Check After Encouraging TUPELO Trial Data and Analyst Upgrades [Yahoo! Finance]
12/21
07:51 am
rxrx
Is Recursion Pharmaceuticals, Inc. (RXRX) the Best Fundamentally Strong Penny Stock to Buy? [Yahoo! Finance]
Low
Report
Is Recursion Pharmaceuticals, Inc. (RXRX) the Best Fundamentally Strong Penny Stock to Buy? [Yahoo! Finance]
11/5/2025
06:30 am
rxrx
recursion pharmaceuticals, inc. - class a
BEAT
Report
1.6%
recursion pharmaceuticals, inc. - class a
8/5/2025
06:30 am
rxrx
recursion pharmaceuticals, inc. - class a
MISS
Report
-6.9%
recursion pharmaceuticals, inc. - class a
5/5/2025
06:00 am
rxrx
recursion pharmaceuticals, inc. - class a
MISS
Report
-15.5%
recursion pharmaceuticals, inc. - class a
2/28/2025
06:30 am
rxrx
recursion pharmaceuticals, inc. - class a
MISS
Report
-5.4%
recursion pharmaceuticals, inc. - class a
12/30
07:35 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Dec 29 Filed by: Taylor Ben R
Low
Report
Form 4 RECURSION PHARMACEUTICAL For: Dec 29 Filed by: Taylor Ben R
12/29
05:25 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Dec 22 Filed by: Khan Najat
Low
Report
Form 4 RECURSION PHARMACEUTICAL For: Dec 22 Filed by: Khan Najat
12/29
09:41 am
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Taylor Ben R
Low
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Taylor Ben R
12/23
07:25 pm
rxrx
Form SCHEDULE 13D/A RECURSION PHARMACEUTICAL Filed by: Mubadala Investment Co PJSC
Low
Report
Form SCHEDULE 13D/A RECURSION PHARMACEUTICAL Filed by: Mubadala Investment Co PJSC
12/22
12:20 pm
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Khan Najat
Low
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Khan Najat
12/19
05:05 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Dec 19 Filed by: Gibson Christopher
Low
Report
Form 4 RECURSION PHARMACEUTICAL For: Dec 19 Filed by: Gibson Christopher
12/19
09:52 am
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher
Medium
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher
12/17
06:34 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Dec 15 Filed by: Taylor Ben R
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Dec 15 Filed by: Taylor Ben R
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register